Filing Details

Accession Number:
0001022079-17-000176
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-07 16:43:31
Reporting Period:
2017-09-05
Accepted Time:
2017-09-07 16:43:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221534 Daniel Stanzione 500 Plaza Drive
Secaucus NJ 07094
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-05 684 $51.55 35,359 No 4 M Direct
Common Stock Acquisiton 2017-09-05 681 $55.76 36,040 No 4 M Direct
Common Stock Acquisiton 2017-09-05 519 $57.67 36,559 No 4 M Direct
Common Stock Acquisiton 2017-09-05 915 $57.57 37,474 No 4 M Direct
Common Stock Acquisiton 2017-09-05 1,004 $61.23 38,478 No 4 M Direct
Common Stock Disposition 2017-09-05 3,803 $108.01 34,675 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2017-09-05 684 $51.55 684 $51.55
Common Stock Stock Options (Right to Buy) Disposition 2017-09-05 681 $55.76 681 $55.76
Common Stock Stock Options (Right to Buy) Disposition 2017-09-05 519 $57.67 519 $57.67
Common Stock Stock Options (Right to Buy) Disposition 2017-09-05 915 $57.57 915 $57.57
Common Stock Stock Options (Right to Buy) Disposition 2017-09-05 1,004 $61.23 1,004 $61.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,316 2019-05-14 No 4 M Direct
7,319 2020-05-06 No 4 M Direct
5,592 2021-05-17 No 4 M Direct
4,268 2022-05-11 No 4 M Direct
5,221 2023-05-21 No 4 M Direct
Footnotes
  1. This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.
  2. This transaction was executed in multiple trades at prices ranging from $108.00 to $108.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The options vested in three annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012.
  4. The options vested in three annual installments beginning with the first on May 6, 2011, the second on May 6, 2012 and the final on May 6, 2013.
  5. The options vested in three annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014.
  6. The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015.
  7. The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.